Analysis of patent litigation, PTAB practice, prosecution and pharma IP, written on the data behind LexDana.
Tagged disclosure · clear
Back in 2021, a Stanford University team of scientists made headlines as they managed to reverse engineer the Moderna Covid-19 vaccine from just drops in discarded vials. The team determined the sequence of the mRNA for the vaccine and later posted it on…
The perfect confidentiality agreements is, in most cases, overkill and in any event would probably never be signed. Hundreds, if not thousands, of CDAs, NDAs and other secrecy agreements are signed every day, and the vast majority perform adequately for…
Before returning to private practice, I practiced patent law in-house at two companies: first at a battery company, and then at an oil company. I’ve sat through my share of invention disclosure committee meetings. This article is intended to help…
The recent decision on Teva Pharmaceutical Industries Ltd. v. Astrazeneca Pharmaceuticals LP raises the issue of ‘secret prior art’ and also raises speculation on how (if at all) the America Invents Act will change the patent landscape in this…
